{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:20:21Z","timestamp":1790958021936,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rhythm Pharmaceuticals, Inc","award":["Rhythm Pharmaceuticals, Inc"],"award-info":[{"award-number":["Rhythm Pharmaceuticals, Inc"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There are no validated measures to assess hyperphagia associated with rare MC4R pathway diseases, such as Bardet-Biedl Syndrome (BBS). Symptoms of Hyperphagia\u00a9 (SoH) and Impacts of Hyperphagia\u00a9 (IoH) are novel questionnaires designed to assess signs and symptoms of hyperphagia and their impacts on patients and caregivers. We evaluated the psychometric performance of the caregiver-versions of the SoH: Caregiver (Observer-reported) and IoH: Caregiver (Observer-reported and Self-reported subscales).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Reliability and validity were evaluated using data from a multi-country cross-sectional survey of adult caregivers of patients with BBS experiencing hyperphagia and obesity. Other instruments included were Impact of Weight on Quality of Life (IWQOL)-Kids (Parent Proxy), PROMIS Scale Global Health of Caregiver, Revised Impact on Family Scale (RIOFS), and Work Productivity and Activity Impairment. 242 eligible caregivers completed the survey. Exploratory factor analysis identified 1 factor per subscale. Strong internal consistency was observed for IoH: Caregiver (Observer) (Cronbach\u2019s a\u2009=\u20090.66) and IoH: Caregiver (Self) (a\u2009=\u20090.72) and moderate for SoH: Caregiver (Observer) (a\u2009=\u20090.40). Moderate-to-strong correlations were observed with school days missed and all domains of IWQOL-Kids except Physical Comfort (range\u2009=\u20090.315\u20130.573, <jats:italic>p\u2019s\u2009&lt;<\/jats:italic>\u20090.001). Known-groups indicated significantly worse SoH: Caregiver subscores for patients using appetite suppressants or implementing more weight management approaches (6\u201310 vs. \u22645 or &gt;\u200910). Caregivers reporting greater strain on RIOFS items and worse mental health had worse IoH subscores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The SoH: Caregiver and IoH: Caregiver demonstrated preliminary validity, reliability, and consistency in a real-world setting. Research is underway to further validate these measures for use in clinical trials for BBS and other MC4R pathway-related diseases associated with obesity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03948-1","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:49:30Z","timestamp":1755848970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychometric evaluation of novel hyperphagia questionnaires in a real-world setting for patients with a rare MC4R pathway disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Jeremy","family":"Pomeroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha G.","family":"Mallya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-6658","authenticated-orcid":false,"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Greatsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Haqq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"3948_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000445061","volume":"9","author":"H Huvenne","year":"2016","unstructured":"Huvenne H, Dubern B, Cl\u00e9ment K, Poitou C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts. 2016;9:158\u201373.","journal-title":"Obes Facts"},{"key":"3948_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ejhg.2012.115","volume":"21","author":"E Forsythe","year":"2013","unstructured":"Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet. 2013;21:8\u201313.","journal-title":"Eur J Hum Genet"},{"key":"3948_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jnnp.2011.241802","volume":"11","author":"JM Pearce","year":"2011","unstructured":"Pearce JM. Disease, diagnosis or syndrome? Pract Neurol. 2011;11:91\u20137.","journal-title":"Pract Neurol"},{"key":"3948_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/PGE-13051","volume":"2","author":"S Castro-Sanchez","year":"2013","unstructured":"Castro-Sanchez S, Alvarez-Satta M, Valverde D. Bardet-Biedl syndrome: a rare genetic disease. J Pediatr Genet. 2013;2:77\u201383.","journal-title":"J Pediatr Genet"},{"key":"3948_CR5","unstructured":"Fehnel S. Qualitative interviews with setmelanotide trial participants. RTI Health Solutions; 2021."},{"key":"3948_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fped.2018.00023","volume":"6","author":"E Forsythe","year":"2018","unstructured":"Forsythe E, Kenny J, Bacchelli C, Beales PL. Managing Bardet-Biedl syndrome-now and in the future. Front Pediatr. 2018;6:23.","journal-title":"Front Pediatr"},{"key":"3948_CR7","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/oby.2007.216","volume":"15","author":"EM Dykens","year":"2007","unstructured":"Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E. Assessment of hyperphagia in Prader-Willi syndrome. Obes (Silver Spring). 2007;15:1816\u201326.","journal-title":"Obes (Silver Spring)"},{"key":"3948_CR8","doi-asserted-by":"publisher","first-page":"A25","DOI":"10.1016\/j.jval.2015.03.154","volume":"18","author":"SE Fehnel","year":"2015","unstructured":"Fehnel SE, Brown TM, Nelson L, et al. Development of the hyperphagia questionnaire for use in Prader-Willi syndrome clinical trials. Value Health. 2015;18:A25.","journal-title":"Value Health"},{"key":"3948_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.appet.2016.12.027","volume":"111","author":"LJ Nolan","year":"2017","unstructured":"Nolan LJ, Geliebter A. Validation of the night eating diagnostic questionnaire (NEDQ) and its relationship with depression, sleep quality, food addiction, and body mass index. Appetite. 2017;111:86\u201395.","journal-title":"Appetite"},{"key":"3948_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MOP.0000000000000641","volume":"30","author":"K Dayton","year":"2018","unstructured":"Dayton K, Miller J. Finding treatable genetic obesity: strategies for success. Curr Opin Pediatr. 2018;30:526\u201331.","journal-title":"Curr Opin Pediatr"},{"key":"3948_CR11","unstructured":"Rhythm. Qualitative interview with clinicians who treat hyperphagia (EVA-24920-00-001). 2020."},{"key":"3948_CR12","unstructured":"Ervin C, Norcross L, Mallya UG et al. Patient-and caregiver-reported experiences of hyperphagia in Bardet-Biedl syndrome before and during setmelanotide treatment. Paper presented at: Hormone Research in Paediatrics; 2022."},{"key":"3948_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13023-022-02602-4","volume":"18","author":"E Forsythe","year":"2023","unstructured":"Forsythe E, Haws RM, Argente J, et al. Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results. Orphanet J Rare Dis. 2023;18:12.","journal-title":"Orphanet J Rare Dis"},{"key":"3948_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13023-023-02692-8","volume":"18","author":"E Forsythe","year":"2023","unstructured":"Forsythe E, Mallya UG, Yang M, et al. Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study. Orphanet J Rare Dis. 2023;18:181.","journal-title":"Orphanet J Rare Dis"},{"key":"3948_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-023-02723-4","volume":"18","author":"E Forsythe","year":"2023","unstructured":"Forsythe E, Mallya UG, Yang M, et al. Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey. Orphanet J Rare Dis. 2023;18:182.","journal-title":"Orphanet J Rare Dis"},{"key":"3948_CR16","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/oby.2008.416","volume":"16","author":"AC Modi","year":"2008","unstructured":"Modi AC, Zeller MH. Validation of a parent-proxy, obesity-specific quality-of-life measure: sizing them up. Obes (Silver Spring). 2008;16:2624\u201333.","journal-title":"Obes (Silver Spring)"},{"key":"3948_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/oby.2006.59","volume":"14","author":"RL Kolotkin","year":"2006","unstructured":"Kolotkin RL, Zeller M, Modi AC, et al. Assessing weight-related quality of life in adolescents. Obes (Silver Spring). 2006;14:448\u201357.","journal-title":"Obes (Silver Spring)"},{"key":"3948_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41687-019-0118-1","volume":"3","author":"YF Jalil","year":"2019","unstructured":"Jalil YF, Villarroel GS, Silva AA, et al. Reliability and validity of the revised impact on family scale (RIOFS) in the hospital context. J Patient Rep Outcomes. 2019;3:28.","journal-title":"J Patient Rep Outcomes"},{"key":"3948_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00004703-200302000-00004","volume":"24","author":"RE Stein","year":"2003","unstructured":"Stein RE, Jessop DJ. The impact on family scale revisited: further psychometric data. J Dev Behav Pediatr. 2003;24:9\u201316.","journal-title":"J Dev Behav Pediatr"},{"key":"3948_CR20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, et al. The Patient-Reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63:1179\u201394.","journal-title":"J Clin Epidemiol"},{"key":"3948_CR21","unstructured":"Hair JFBW, Babin BJ, Anderson RE. Multivariate data analysis. 7th ed. Pearson; 2010."},{"key":"3948_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/nur.4770140211","volume":"14","author":"S Ferketich","year":"1991","unstructured":"Ferketich S. Focus on psychometrics. Aspects of item analysis. Res Nurs Health. 1991;14:165\u20138.","journal-title":"Res Nurs Health"},{"key":"3948_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12691\/ajams-9-1-2","volume":"9","author":"N Shrestha","year":"2021","unstructured":"Shrestha N. Factor analysis as a tool for survey analysis. Am J Appl Math Stat. 2021;9:4\u201311.","journal-title":"Am J Appl Math Stat"},{"key":"3948_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112:155\u20139.","journal-title":"Psychol Bull"},{"key":"3948_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s12325-022-02059-8","volume":"39","author":"M Wabitsch","year":"2022","unstructured":"Wabitsch M, Fehnel S, Mallya UG, et al. Understanding the patient experience of hunger and improved quality of life with setmelanotide treatment in POMC and LEPR deficiencies. Adv Ther. 2022;39:1772\u201383.","journal-title":"Adv Ther"},{"key":"3948_CR26","doi-asserted-by":"publisher","first-page":"e0140705","DOI":"10.1371\/journal.pone.0140705","volume":"10","author":"B Hamlington","year":"2015","unstructured":"Hamlington B, Ivey LE, Brenna E, Biesecker LG, Biesecker BB, Sapp JC. Characterization of courtesy stigma perceived by parents of overweight children with Bardet-Biedl syndrome. PLoS ONE. 2015;10:e0140705.","journal-title":"PLoS ONE"},{"key":"3948_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/fampra\/cmh729","volume":"22","author":"LD Edmunds","year":"2005","unstructured":"Edmunds LD. Parents\u2019 perceptions of health professionals\u2019 responses when seeking help for their overweight children. Fam Pract. 2005;22:287\u201392.","journal-title":"Fam Pract"},{"key":"3948_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/chi.2021.0003","volume":"17","author":"AM Haqq","year":"2021","unstructured":"Haqq AM, Kebbe M, Tan Q, Manco M, Salas XR. Complexity and stigma of pediatric obesity. Child Obes. 2021;17:229\u201340.","journal-title":"Child Obes"},{"key":"3948_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/cob.12202","volume":"7","author":"IS Zenlea","year":"2017","unstructured":"Zenlea IS, Thompson B, Fierheller D, et al. Walking in the shoes of caregivers of children with obesity: supporting caregivers in paediatric weight management. Clin Obes. 2017;7:300\u20136.","journal-title":"Clin Obes"},{"key":"3948_CR30","doi-asserted-by":"publisher","first-page":"103856","DOI":"10.1016\/j.ejmg.2020.103856","volume":"63","author":"D Zelihic","year":"2020","unstructured":"Zelihic D, Hjardemaal FR, Lippe CV. Caring for a child with Bardet-Biedl syndrome: a qualitative study of the parental experiences of daily coping and support. Eur J Med Genet. 2020;63:103856.","journal-title":"Eur J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03948-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03948-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03948-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:27:45Z","timestamp":1757446065000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03948-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3948"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03948-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments and was granted an exemption from a full review by the United States Pearl Institutional Review Board according to FDA 21 CFR 56.104 and 45CFR46.104(b)(2): (2) Tests, Surveys, Interviews on 07\/01\/2021","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"UM and CH are full-time employees of Rhythm Pharmaceuticals, Inc. and have received company-awarded stocks or stock options. MY, AG, and EH are or were employees of Analysis Group, which received funding for supporting this research. JP\u2019s institution received research support from Rhythm Pharmaceuticals as a co-investigator of clinical trials. AH is an advisory Board Member for Rhythm Pharmaceuticals, Inc., Novo Nordisk, Foundation for Prader-Willi Research USA; a grant Recipient for Weston Family Microbiome Initiative and Canadian Institutes of Health Research; and is primary investigator on clinical trials with Rhythm Pharmaceuticals, Inc., Acadia Pharmaceuticals and Eli Lilly.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}